retatrutide cause cancer vs Semaglutide and Tirzepatide: GLP-3 Facts explained Acute and chronic effects of

Signs of an allergic reaction (trouble breathing, swelling, hives)

A handful of glucagon-like peptide-1 (GLP-1) agonists have received US Food and Drug Administration (FDA) approval for obesity treatmentincluding liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound)while others, like exenatide (Byetta, Bydureon), liraglutide (Victoza), semaglutide (Ozempic, Rybelsus), and tirzepatide (again, known as Mounjaro for the diabetes indication), are indicated for type 2 diabetes

Report any new joint symptoms promptly so they can be assessed and documented appropriately

This is the trap that leads to rapid weight regain if you ever stop the medication

Support group for social support, encouragement, and accountability from others with similar goals

Choose a time that fits your schedule and stick with it for consistency